Literature DB >> 24399298

25 Years of neuroendocrine neoplasms of the gastrointestinal tract.

G Rindi1, G Petrone, F Inzani.   

Abstract

This paper provides a personal pathologist's view of how neuroendocrine tumors (NET) were perceived and defined in the last quarter of a century. In years when the Helicobacter pylori, omeprazole and the adenoma-carcinoma sequence in colon carcinogenesis significantly impacted on gastrointestinal (GI) pathology daily practice, neuroendocrine neoplasms of the GI tract passed from the original carcinoid definition to the current NET and neuroendocrine carcinoma (NEC) definitions. The development of different concepts, basic tumor biology knowledge, tools for pathology diagnosis and the various World Health Organization (WHO) classifications from 1980 through 2010 are briefly reviewed and discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24399298     DOI: 10.1007/s12022-013-9292-5

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  47 in total

Review 1.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

2.  Specific endocrine tissue marker defined by a monoclonal antibody.

Authors:  R V Lloyd; B S Wilson
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

3.  Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Authors:  David S Klimstra; Irvin R Modlin; N Volkan Adsay; Runjan Chetty; Vikram Deshpande; Mithat Gönen; Robert T Jensen; Mark Kidd; Matthew H Kulke; Ricardo V Lloyd; Cesar Moran; Steven F Moss; Kjell Oberg; Dermot O'Toole; Guido Rindi; Marie E Robert; Saul Suster; Laura H Tang; Chin-Yuan Tzen; Mary Kay Washington; Betram Wiedenmann; James Yao
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 4.  Neuroendocrine neoplasms of the gut and pancreas: new insights.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2011-08-02       Impact factor: 43.330

5.  Survival and prognostic factors in patients with small bowel carcinoid tumour.

Authors:  K Landerholm; N Zar; R E Andersson; S E Falkmer; J Järhult
Journal:  Br J Surg       Date:  2011-08-19       Impact factor: 6.939

6.  Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.

Authors:  Côme Lepage; Bernard Rachet; Michel Philippe Coleman
Journal:  Gastroenterology       Date:  2007-01-05       Impact factor: 22.682

Review 7.  Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.

Authors:  G Rindi; V Villanacci; A Ubiali
Journal:  Digestion       Date:  2000       Impact factor: 3.216

Review 8.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

9.  Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours.

Authors:  R Buffa; G Rindi; F Sessa; A Gini; C Capella; R Jahn; F Navone; P De Camilli; E Solcia
Journal:  Mol Cell Probes       Date:  1987-12       Impact factor: 2.365

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  4 in total

1.  SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.

Authors:  Jeffrey A Norton; Teresa Kim; Joseph Kim; Martin D McCarter; Kaitlyn J Kelly; Joyce Wong; Jason K Sicklick
Journal:  J Gastrointest Surg       Date:  2017-08-14       Impact factor: 3.452

Review 2.  Cyto-histology in NET: what is necessary today and what is the future?

Authors:  Frediano Inzani; Gianluigi Petrone; Guido Fadda; Guido Rindi
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 3.  Gastric neuroendocrine neoplasms: a primer for radiologists.

Authors:  Molly E Roseland; Isaac R Francis; Kimberly L Shampain; Erica B Stein; Ashish P Wasnik; John D Millet
Journal:  Abdom Radiol (NY)       Date:  2022-04-12

Review 4.  Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.

Authors:  E T Aristizabal Prada; C J Auernhammer
Journal:  Endocr Connect       Date:  2017-11-16       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.